Asymchem Laboratories (Tianjin) Co., Ltd. (HKG:6821)

Market Cap	28.84B
Revenue (ttm)	6.18B
Net Income (ttm)	1.01B
Shares Out	n/a
EPS (ttm)	2.86
PE Ratio	28.56
Forward PE	n/a
Dividend	1.98 (3.45%)
Ex-Dividend Date	Jun 13, 2024

Volume	805,280
Average Volume	490,716
Open	56.75
Previous Close	58.30
Day's Range	54.50 - 59.35
52-Week Range	37.60 - 74.50
Beta	0.26
RSI	48.99
Earnings Date	Mar 29, 2025

About HKG:6821

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers process development and optimization, analytical, and scale-up services for small molecule drug products throughout the pre-clinical and clinical stage; and ton-scale manufacturing services for registered starting materials, advanced intermediates, and active pharmaceutical ingredients. It also engages in pre-formulation and formulation development; provision of chemical m...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 9,788
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6821

Financial Performance

In 2024, HKG:6821's revenue was 5.80 billion, a decrease of -25.82% compared to the previous year's 7.83 billion. Earnings were 948.95 million, a decrease of -58.17%.

Financial numbers in CNY